Evidence map›Paper›PMID 30404157›Full record

ArticleInternational journal of molecular sciences2018

The Mitochondrial Genes

James J Phelan, Finbar MacCarthy, Dermot O'Toole, Narayanasamy Ravi, John V Reynolds, Jacintha O'Sullivan

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

James J PhelanTrinity Translational Medicine Institute, Department of Surgery, St. James's Hospital, D08W9RT Dublin, Ireland. phelanj1@tcd.ie.
Finbar MacCarthyDepartment of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin and St. James's Hospital, D08W9RT Dublin, Ireland. finbarmaccarthy@gmail.com.
Dermot O'TooleDepartment of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin and St. James's Hospital, D08W9RT Dublin, Ireland. otooled1@tcd.ie.
Narayanasamy RaviTrinity Translational Medicine Institute, Department of Surgery, St. James's Hospital, D08W9RT Dublin, Ireland. ravisec@stjames.ie.
John V ReynoldsTrinity Translational Medicine Institute, Department of Surgery, St. James's Hospital, D08W9RT Dublin, Ireland. reynoldsjv@stjames.ie.
Jacintha O'SullivanTrinity Translational Medicine Institute, Department of Surgery, St. James's Hospital, D08W9RT Dublin, Ireland. osullij4@tcd.ie.
Trinity College Dublin · IESt. James's Hospital · IE

Funding

Science Foundation Ireland SFI 11/RFP.1/CAN/3137
6 · The paper itself

Abstract

Barrett's esophagus and esophageal cancer lack prognostic markers that allow the tailoring of personalized medicine and biomarkers with potential to provide insight into treatment response. This study aims to characterize mitochondrial function across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's esophagus and examines the functional effect of manipulating mitochondrial genes. Mitochondrial genes of interest were validated in in vitro cell lines across the metaplasia (QH), dysplasia (GO) and adenocarcinoma (OE33) sequence and in in vivo patient tissue samples. These genes were subsequently knocked down in QH and OE33 cells and the functional effect of siRNA-induced knockdown on reactive oxygen species production, mitochondrial mass, mitochondrial membrane potential and cellular metabolism was investigated. Three global mitochondrial genes (

Indexed as

Genes, Mitochondrial14-3-3 ProteinsBarrett Esophagusbcl-2 Homologous Antagonist-Killer ProteinBiomarkers, TumorCell LineExoribonucleasesGene Expression ProfilingGene Knockdown TechniquesHumansMembrane Potential, MitochondrialMembrane ProteinsMitochondriaMitochondrial ProteinsModels, BiologicalReactive Oxygen Species14-3-3 ProteinsBAK1 protein, humanbcl-2 Homologous Antagonist-Killer ProteinBiomarkers, TumorExoribonucleasesFIS1 protein, humanMembrane ProteinsMitochondrial ProteinsReactive Oxygen SpeciesSFN protein, humanBarrett’s metaplasiaesophageal cancermitochondrial dysfunctionmitochondrial genesmitochondrial membrane potential.

Identifiers

PMID30404157
PMCPMC6275077
OpenAlexW2899573561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.